Repro Med Financials
| KRMD Stock | USD 2.08 0.15 6.73% |
With this module, you can analyze Repro financials for your investing period. You should be able to track the changes in Repro Med individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Repro |
Understanding current and past Repro Med Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Repro Med's financial statements are interrelated, with each one affecting the others. For example, an increase in Repro Med's assets may result in an increase in income on the income statement.
The data published in Repro Med's official financial statements usually reflect Repro Med's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Repro Med Systems. For example, before you start analyzing numbers published by Repro accountants, it's critical to develop an understanding of what Repro Med's liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of Repro Med's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Repro Med's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Repro Med's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Repro Med Systems. Please utilize our Beneish M Score to check the likelihood of Repro Med's management manipulating its earnings.
Repro Med Stock Summary
Repro Med competes with Precision Optics, InfuSystems Holdings, Utah Medical, Milestone Scientific, and Merit Medical. KORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Chester, New York. Koru Medical operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 77 people.Specialization | Health Care, Health Care Equipment & Services |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US7599101026 |
| CUSIP | 759910102 |
| Location | New York; U.S.A |
| Business Address | 100 Corporate Drive, |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | NYSE Composite |
| Website | www.korumedical.com |
| Phone | 800 624 9600 |
| Currency | USD - US Dollar |
You should never invest in Repro Med without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Repro Stock, because this is throwing your money away. Analyzing the key information contained in Repro Med's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Repro Med Key Financial Ratios
Generally speaking, Repro Med's financial ratios allow both analysts and investors to convert raw data from Repro Med's financial statements into concise, actionable information that can be used to evaluate the performance of Repro Med over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Repro Med Systems reports annually and quarterly.Repro Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Repro Med's current stock value. Our valuation model uses many indicators to compare Repro Med value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Repro Med competition to find correlations between indicators driving Repro Med's intrinsic value. More Info.Repro Med Systems is rated below average in return on equity category among related companies. It is rated below average in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Repro Med by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Repro Med's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Repro Med's earnings, one of the primary drivers of an investment's value.Repro Med Systems Systematic Risk
Repro Med's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Repro Med volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Repro Med Systems correlated with the market. If Beta is less than 0 Repro Med generally moves in the opposite direction as compared to the market. If Repro Med Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Repro Med Systems is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Repro Med is generally in the same direction as the market. If Beta > 1 Repro Med moves generally in the same direction as, but more than the movement of the benchmark.
About Repro Med Financials
What exactly are Repro Med Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Repro Med's income statement, its balance sheet, and the statement of cash flows. Potential Repro Med investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Repro Med investors may use each financial statement separately, they are all related. The changes in Repro Med's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Repro Med's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Steps to analyze Repro Med Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Repro Med is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Repro has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Repro Med's financials are consistent with your investment objective using the following steps:- Review Repro Med's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Repro Med's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Repro Med's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Repro Med's stock is overvalued or undervalued.
Repro Med April 16, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Repro Med help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Repro Med Systems. We use our internally-developed statistical techniques to arrive at the intrinsic value of Repro Med Systems based on widely used predictive technical indicators. In general, we focus on analyzing Repro Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Repro Med's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.39 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 19.41 | |||
| Value At Risk | (6.07) | |||
| Potential Upside | 5.39 |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Repro Med Systems. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Complementary Tools for Repro Stock analysis
When running Repro Med's price analysis, check to measure Repro Med's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repro Med is operating at the current time. Most of Repro Med's value examination focuses on studying past and present price action to predict the probability of Repro Med's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repro Med's price. Additionally, you may evaluate how the addition of Repro Med to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |
Is Repro Med's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Repro Med. If investors know Repro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Repro Med listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Repro Med Systems is measured differently than its book value, which is the value of Repro that is recorded on the company's balance sheet. Investors also form their own opinion of Repro Med's value that differs from its market value or its book value, called intrinsic value, which is Repro Med's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Repro Med's market value can be influenced by many factors that don't directly affect Repro Med's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Repro Med's value and its price as these two are different measures arrived at by different means. Investors typically determine if Repro Med is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Repro Med's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.